Androgenetic alopecia (AGA)
Conditions
Interventions
Intervention Group:autologous hair follicle unit cell transplantation
Control Group:Finasteride 1mg qd
Sponsors
Dermatology Hospital of Shandong First Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 49 Years
Inclusion criteria
Inclusion criteria: 1.Aged 18-49years, male; 2.Clinical diagnosis of AGA at the time of screening according to the Chinese Guidelines for the Diagnosis and Treatment of Androgenetic Alopecia 2014; 3.The Norwood-Hamilton grade for male hair loss was III-v~V; 4.No alopecia treatment, systemic or topical medications with hair regrowth effects, and physical therapy in the 6 month prior to inclusion; 5.Voluntary participation in this clinical study.
Exclusion criteria
Exclusion criteria: 1.Combined with other types of hair loss such as patchy baldness, scarring alopecia, etc. 2.hose who are allergic to any of the components of the applied drugs; 3.Patients who are afraid of needles or faint of needles; 4.Patients with blood system diseases such as coagulation disorders, or patients with Scalp Psoriasis, severe seborrheic dermatitis, severe Folliculitis, serious Infections, and other diseases that make it difficult to stop bleeding after injury; 5.Moderate to severe abnormalities of liver and kidney function, or suffering from serious organic or systemic diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement rate from baseline in target area non-vellus hair count (TAHC); | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in hair follicle density per unit area in the target region compared to baseline;Change in Hamilton–Norwood grade relative to baseline;Adverse Event (AE);Change from baseline in mean non-vellus hair shaft diameter in the target area;Change in target area hair density per unit area relative to baseline; | — |
Countries
China
Contacts
Public ContactGuoyan Liu
Dermatology Hospital of Shandong First Medical University
Outcome results
None listed